Inivata_CMYK_Logo.jpg
US Commercial Launch of InVisionFirst®-Lung
June 29, 2020 08:48 ET | Inivata
US Commercial Launch of InVisionFirst®-Lung Inivata’s Liquid Biopsy Test for Advanced Non-Small Cell Lung Cancer is Now Available Through NeoGenomics in the US Research Triangle Park, NC, USA and...
Inivata_CMYK_Logo.jpg
Inivata to Present Data at AACR Virtual Annual Meeting Highlighting Capabilities and Clinical Application of RaDaR™ Assay
June 22, 2020 09:32 ET | Inivata
Inivata to Present Data at AACR Virtual Annual Meeting Highlighting Capabilities and Clinical Application of RaDaR™ Assay Personalized assay for detection of residual disease and recurrence...
Inivata_CMYK_Logo.jpg
Inivata Joins Blood Profiling Atlas in Cancer (BloodPAC) Consortium
June 18, 2020 07:00 ET | Inivata
Inivata Joins Blood Profiling Atlas in Cancer (BloodPAC) Consortium Research Triangle Park, NC, USA and Cambridge, UK, 18 June 2020 - Inivata, a leader in liquid biopsy, announces that it has...
Inivata_CMYK_Logo.jpg
Inivata and Collaborators to Present New Data from the RaDaR™ Assay at AACR Virtual Annual Meeting II
June 04, 2020 07:00 ET | Inivata
Inivata and Collaborators to Present New Data from the RaDaR™ Assay at AACR Virtual Annual Meeting II Data will showcase capabilities of newly launched liquid biopsy assay for the detection of...
Inivata_CMYK_Logo.jpg
Inivata Announces Strategic Collaboration and Investment from NeoGenomics
May 26, 2020 05:06 ET | Inivata
Inivata Announces Strategic Collaboration and Investment from NeoGenomics NeoGenomics will commercialize Inivata’s InVisionFirst®-Lung liquid biopsy test in the United States Inivata and...
Inivata_CMYK_Logo.jpg
Inivata Offers Mobile Phlebotomy Services for patients undergoing InVisionFirst® Lung ctDNA liquid biopsy
May 12, 2020 07:00 ET | Inivata
Inivata Offers Mobile Phlebotomy Services for patients  undergoing InVisionFirst® Lung ctDNA liquid biopsy Research Triangle Park, NC, USA May 12, 2020 – Inivata (www.inivata.com) a leader in...
Inivata_CMYK_Logo.jpg
Inivata Launches RaDaR™ Assay for Detection of Residual Disease and Recurrence
April 23, 2020 07:00 ET | Inivata
Inivata Launches RaDaR™ Assay for Detection of Residual Disease and Recurrence  Personalized multi-tumor test provides potential new option for the rapid and sensitive identification of...
Inivata_CMYK_Logo.jpg
Inivata and the European Organisation for Research and Treatment of Cancer (EORTC) collaborate in Phase II NSCLC study
October 29, 2019 07:00 ET | Inivata
                                                            Inivata and the European Organisation for Research and Treatment of Cancer (EORTC) collaborate in Phase II NSCLC study   Inivata to...
Inivata_CMYK_Logo.jpg
Novel approach based on InVision® liquid biopsy platform predicts response to immune checkpoint inhibitors
October 08, 2019 07:00 ET | Inivata
  Novel approach based on InVision® liquid biopsy platform predicts response to immune checkpoint inhibitors New peer-reviewed publication outlines an approach that identifies NSCLC patients who...
Inivata_CMYK_Logo.jpg
Inivata to Present New Clinical Data on the Utility of Liquid Biopsy and InVisionFirst®-Lung at World Conference on Lung Cancer 2019
August 29, 2019 07:00 ET | Inivata
Inivata to Present New Clinical Data on the Utility of Liquid Biopsy and InVisionFirst®-Lung at World Conference on Lung Cancer 2019 Oral presentation and posters to feature Inivata’s...